These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28551622)

  • 1. Protein Complex of Fibrinogen Gamma Chain and Complement Factor H in Ovarian Cancer Patient Plasma.
    Honda KI; Asada R; Kageyama K; Fukuda T; Terada H; Yasui T; Sumi T; Koyama M; Ishiko O; Sugawa T
    Anticancer Res; 2017 Jun; 37(6):2861-2866. PubMed ID: 28551622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains.
    Siebenlist KR; Meh DA; Mosesson MW
    Biochemistry; 1996 Aug; 35(32):10448-53. PubMed ID: 8756701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma fibrinogen levels in patients with benign and malignant ovarian tumors.
    Hefler-Frischmuth K; Lafleur J; Hefler L; Polterauer S; Seebacher V; Reinthaller A; Grimm C
    Gynecol Oncol; 2015 Mar; 136(3):567-70. PubMed ID: 25576886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin binding to the A alpha-, B beta-, and gamma-chains of fibrinogen and to their remnants contained in fragment E.
    Kaczmarek E; McDonagh J
    J Biol Chem; 1988 Sep; 263(27):13896-900. PubMed ID: 3417681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter study.
    Polterauer S; Grimm C; Seebacher V; Concin N; Marth C; Tomovski C; Husslein H; Leipold H; Hefler-Frischmuth K; Tempfer C; Reinthaller A; Hefler L
    Oncologist; 2009 Oct; 14(10):979-85. PubMed ID: 19776095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct evidence for systemic fibrinogenolysis in a patient with metastatic prostatic cancer.
    Okajima K; Kohno I; Tsuruta J; Okabe H; Takatsuki K; Binder BR
    Thromb Res; 1992 Jun; 66(6):717-27. PubMed ID: 1519230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement C3 is a novel plasma clot component with anti-fibrinolytic properties.
    Howes JM; Richardson VR; Smith KA; Schroeder V; Somani R; Shore A; Hess K; Ajjan R; Pease RJ; Keen JN; Standeven KF; Carter AM
    Diab Vasc Dis Res; 2012 Jul; 9(3):216-25. PubMed ID: 22253322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmic degradation of fibrinogen Paris I.
    Budzynski AZ; Marder VJ
    J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of three gamma-chains with different molecular weights from normal human plasma fibrinogen.
    Francis CW; Keele EM; Marder VJ
    Biochim Biophys Acta; 1984 Mar; 797(3):328-35. PubMed ID: 6696949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. gamma and alpha chains of human fibrinogen possess sites reactive with human platelet receptors.
    Hawiger J; Timmons S; Kloczewiak M; Strong DD; Doolittle RF
    Proc Natl Acad Sci U S A; 1982 Mar; 79(6):2068-71. PubMed ID: 6281794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor VIIIR:Ag plasma levels in patients with cervical and ovarian carcinoma.
    Facchini V; Gadducci A; Baicchi U; Del Bravo B; Vispi M; Teti G; Fioretti P
    Eur J Gynaecol Oncol; 1988; 9(1):87-93. PubMed ID: 3126071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of phosphorylated fibrinogen-alpha-isoforms and differential expression of other post-translationally modified proteins in the plasma of ovarian cancer patients.
    Ogata Y; Heppelmann CJ; Heppelmann CJ; Charlesworth MC; Madden BJ; Miller MN; Kalli KR; Cliby WA; Bergen HR; Saggese DA; Muddiman DC
    J Proteome Res; 2006 Dec; 5(12):3318-25. PubMed ID: 17137333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The correlation between plasma fibrinogen levels and the clinical features of patients with ovarian carcinoma.
    Ma Y; Qian Y; Lv W
    J Int Med Res; 2007; 35(5):678-84. PubMed ID: 17900407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen binding to human blood platelets: effect of gamma chain carboxyterminal structure and length.
    Peerschke EI; Francis CW; Marder VJ
    Blood; 1986 Feb; 67(2):385-90. PubMed ID: 3942829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of fibrinogen A alpha-chain by affinity chromatography on concanavalin A-sepharose.
    Bögli C; Hofer A; Furlan M
    Thromb Haemost; 1988 Oct; 60(2):308-10. PubMed ID: 3217923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a tool for prediction of ovarian cancer in patients with adnexal masses: Value of plasma fibrinogen.
    Seebacher V; Aust S; D'Andrea D; Grimm C; Reiser E; Tiringer D; Von Mersi H; Polterauer S; Reinthaller A; Helmy-Bader S
    PLoS One; 2017; 12(8):e0182383. PubMed ID: 28837575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of the complement-component-C3b-binding site and the cofactor activity for factor I in the 38kDa tryptic fragment of factor H.
    Alsenz J; Lambris JD; Schulz TF; Dierich MP
    Biochem J; 1984 Dec; 224(2):389-98. PubMed ID: 6240261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant proteases from western diamondback rattlesnake (Crotalus atrox) venom.
    Pandya BV; Budzynski AZ
    Biochemistry; 1984 Jan; 23(3):460-70. PubMed ID: 6367819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma fibrin clot proteomics in healthy subjects: Relation to clot permeability and lysis time.
    Ząbczyk M; Stachowicz A; Natorska J; Olszanecki R; Wiśniewski JR; Undas A
    J Proteomics; 2019 Sep; 208():103487. PubMed ID: 31425886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor H is a dermatan sulfate-binding protein: identification of a dermatan sulfate-mediated protease that cleaves factor H.
    Saito A; Munakata H
    J Biochem; 2005 Feb; 137(2):225-33. PubMed ID: 15749837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.